Dear Users
To provide more trading options and enhance the user trading experience, Megabit will launch SHELL/USDT perpetual futures on February 25, 2025, at 18:00 (SGT TIME). These Futures will offer up to 75x leverage.
Below are the details of the perpetual futures:
| USDT-Margined Perpetual Futures | SHELL/USDT |
| Launch Time | February 25, 2025, 18:00 (SGT TIME) |
| Underlying Asset | MyShell (SHELL) |
| Project Info |
MyShel is an AI consumer application platform that allows everyone to create, share, and own AI agents. Through a no-code AI agent development framework, self-developed AI open-source models, and an active creator community, we have built a bridge between cutting-edge AI technology and blockchain. While providing AI-driven entertainment value to users, we also offer the crypto community the opportunity to share ownership. |
| Settlement Asset | USDT |
| Tick Size0.001 | 0.0001 |
| Price Precision0.001 | 0.0001 |
| Trading Fee Rate | maker:0.05% taker 0.05% |
| Capped Funding Rate | +2%/-2% |
| Funding Fee Settlement Frequency | Every 4 hours |
| Maximum Leverage | 75× |
| Trading Time | 7×24 |
Important Notes:
- At launch, The maximum funding rate for the above perpetual futures will be +2%/-2%.
- The funding fee settlement frequency is every four hours.
- Based on market risk conditions, Megabit reserves the right to adjust futures parameters, including funding rates, minimum price increments, maximum leverage, initial margin, maintenance margin, and other critical parameters.
Risk Disclaimer
Cryptographic assets offer high growth potential but also come with significant market risks and volatility. We strongly recommend that users make investment decisions independently after fully understanding the risks involved and take full responsibility for their choices.
If you have any questions, please feel free to contact the official Megabit team.
Megabit Team
February 25, 2025
Official Website | 𝕏 | Telegram (Chinese Group) | Telegram (English Group)
Comments
0 comments
Article is closed for comments.